Turbo Cancer

Revolutionizing Cancer Treatment: Dr. William Makis Unveils Turbo Cancer and the Power of Repurposed Drugs

In a groundbreaking presentation for GoldCare Grand Rounds, Dr. William Makis, leading North American expert in Nuclear Medicine, Targeted Radionuclide Therapy, and Theranostics, for an insightful talk on cutting-edge cancer treatments, shared his pioneering research on repurposed drugs and their transformative potential in the fight against cancer. With over a decade of frontline experience and a courageous stand against systemic challenges in Canadian healthcare, Dr. Makis has emerged as a leading voice in innovative cancer therapies.

Dr. Makis’s journey into repurposed drugs began during the COVID-19 pandemic, where he witnessed the life-saving potential of medications like ivermectin and hydroxychloroquine. This sparked a deeper exploration into their applications beyond their original uses, leading to astonishing discoveries in cancer treatment. His research reveals that these off-patent, cost-effective drugs—often dismissed by mainstream oncology—hold the key to unlocking new, curative approaches to cancer.

Ivermectin: A Game-Changer in Cancer Therapy

Dr. Makis highlighted ivermectin, an anti-parasitic drug, as a potent anticancer agent with at least 15 identified mechanisms of action. From inhibiting cancer stem cells—often responsible for recurrence and metastasis—to reversing multidrug resistance in aggressive cancers like pancreatic and ovarian cancer, ivermectin has shown remarkable success. Dr. Makis shared inspiring case studies of stage IV cancer patients achieving complete remission through a combination of ivermectin and traditional therapies.

Fenbendazole: The "Dog Dewormer" That Defies Cancer

Another star in Dr. Makis’s research is fenbendazole, a veterinary drug popularized by Joe Tippens, who cured his stage IV small cell lung cancer using this unconventional treatment. Dr. Makis explained how fenbendazole disrupts cancer cell metabolism, inhibits tumor growth, and stimulates apoptosis, offering hope to patients who have exhausted conventional treatment options.

A Call to Action for the Medical Community

Dr. Makis’s work underscores the urgent need for the medical community to embrace repurposed drugs. Despite overwhelming preclinical evidence, the lack of financial incentives has stifled human trials and widespread adoption. He urged healthcare practitioners to explore these therapies, emphasizing their minimal risk and profound potential to save lives.

Turbo Cancers and the Vaccine Connection

In a sobering segment, Dr. Makis addressed the rise of "turbo cancers"—aggressive, fast-growing cancers in young people—which he believes are linked to COVID-19 vaccines. His extensive research and advocacy have brought attention to this alarming trend, urging further investigation and preparedness for a potential tsunami of cancer cases in the coming years.

Empowering Patients, Transforming Lives

Through his cancer coaching practice, Dr. Makis has guided over 2,000 patients in using repurposed drugs, providing education, dosing guidance, and support. His approach empowers patients to take control of their health, often achieving remarkable outcomes where traditional treatments have failed.

Dr. Makis’s presentation is a clarion call for innovation, courage, and compassion in medicine. By challenging the status quo and embracing repurposed drugs, we can revolutionize cancer treatment and offer new hope to millions.

Join the Movement

Discover the transformative potential of repurposed drugs and learn how you can be part of this medical revolution. Watch Dr. William Makis’s full presentation and explore the future of cancer therapy today.  

‍

‍